At a glance
ClinicalIndex Comparison RecordPhase 3Completed· 53 enrolled
Drug / intervention
OPIOID +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Opioid Analgesic Reduction Study (OARS) - Pilot
In Brief
A Phase 3 clinical trial evaluating OPIOID and NON-OPIOID for Post Operative Pain. Completed, enrolled 53 participants across 5 sites.
Detailed Summary
The purpose of this study is to test protocols being developed for the conduct of a large sale multi-site clinical trial which will compare opioids to non-opioids for managing post-surgical impacted 3rd molar extraction pain.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPost Operative Pain
CountriesUnited States
Timeline
Phase 3CompletedFinished
202120222023202420252026
Enrollment StartJul 2020
Primary CompletionMar 2021
Study CompletionMar 2021
First PostedMar 2022
TodayJul 2026
First PostedMar 17, 2022
Enrollment StartJul 6, 2020
Primary CompletionMar 12, 2021
Study CompletionMar 26, 2021
TodayJul 2, 2026
Enrollment to primary: 8 monthsPosted 4.3 years ago
Interventions
OPIOIDdrug
Analgesic assignment
NON-OPIOIDdrug
Analgesic assignment